Handelsbanken Fonder
CRL icon

Handelsbanken Fonder’s Charles River Laboratories CRL Stock Holding History

Handelsbanken Fonder’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.38M Buy
19,306
+5,200
+37% +$926K 0.01% 532
2026
Q1 		$2.43M Hold
14,106
– – 0.01% 665
2025
Q4 		$2.81M Sell
14,106
-500
-3% -$90.7K 0.01% 630
2025
Q3 		$2.29M Buy
14,606
+3,069
+27% +$487K 0.01% 683
2025
Q2 		$1.75M Hold
11,537
– – 0.01% 712
2025
Q1 		$1.74M Sell
11,537
-900
-7% -$151K 0.01% 705
2024
Q4 		$2.3M Buy
12,437
+200
+2% +$38.5K 0.01% 623
2024
Q3 		$2.41M Buy
12,237
+1,900
+18% +$395K 0.01% 602
2024
Q2 		$2.13M Buy
10,337
+1,500
+17% +$340K 0.01% 571
2024
Q1 		$2.39M Hold
8,837
– – 0.01% 557
2023
Q4 		$2.09M Buy
8,837
+200
+2% +$39.3K 0.01% 548
2023
Q3 		$1.69M Buy
8,637
+800
+10% +$164K 0.01% 581
2023
Q2 		$1.65M Buy
7,837
+800
+11% +$159K 0.01% 584
2023
Q1 		$1.42M Hold
7,037
– – 0.01% 598
2022
Q4 		$1.53M Buy
7,037
+100
+1% +$21.8K 0.01% 558
2022
Q3 		$1.36M Hold
6,937
– – 0.01% 578
2022
Q2 		$1.48M Sell
6,937
-900
-11% -$220K 0.01% 587
2022
Q1 		$2.23M Hold
7,837
– – 0.01% 564
2021
Q4 		$2.95M Hold
7,837
– – 0.01% 553
2021
Q3 		$3.23M Sell
7,837
-200
-2% -$83.1K 0.02% 542
2021
Q2 		$2.97M Sell
8,037
-1,600
-17% -$534K 0.02% 559
2021
Q1 		$2.79M Hold
9,637
– – 0.02% 545
2020
Q4 		$2.41M Hold
9,637
– – 0.01% 570
2020
Q3 		$2.18M Hold
9,637
– – 0.02% 542
2020
Q2 		$1.68M Buy
+9,637
New +$1.54M 0.01% 559

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Handelsbanken Fonder's CRL Position: Q2 2026 in Review

Handelsbanken Fonder increased its Charles River Laboratories (CRL) stake by 37% in Q2 2026, buying an estimated $926K and bringing the position to 19,306 shares worth $4.38M. The position accounts for 0.01% of the portfolio, ranked #532.

Handelsbanken Fonder first reported a position in CRL in Q2 2020 and has held it in 25 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Handelsbanken Fonder held 19,306 shares of Charles River Laboratories worth $4.38M as of Q2 2026.
  • Handelsbanken Fonder bought 5,200 Charles River Laboratories shares in Q2 2026, an estimated $926K.
  • Charles River Laboratories made up 0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #532 holding.
  • Handelsbanken Fonder first reported a position in Charles River Laboratories in Q2 2020 and has held it in 25 quarters since.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.